3 Beaten Down Biotech Stocks to Buy Now
The share prices of Dynavax Technologies, CellDex Therapeutics, and Clovis Oncology have all plunged this year. Here is why I think these beaten down biotechs are now compelling buys.
Big News for These 5 Stocks From ESMO
But smaller biotechs Clovis Oncology and Exelixis also benefit from the big boys' data.